Literature DB >> 32968108

Effects of early ketamine exposure on cerebral gray matter volume and functional connectivity.

Chia-Chun Hung1,2, Yi-Hsuan Liu3, Chu-Chung Huang4, Cheng-Ying Chou5, Chun-Ming Chen6, Jeng-Ren Duann7,8, Chiang-Shan R Li9,10, Tony Szu-Hsien Lee11,12, Ching-Po Lin13.   

Abstract

Ketamine has been used for medical purposes, most typically as an anesthetic, and recent studies support its use in the treatment of depression. However, ketamine tends to be abused by adolescents and young adults. In the current study, we examined the effects of early ketamine exposure on brain structure and function. We employed MRI to assess the effects of ketamine abuse on cerebral gray matter volume (GMV) and functional connectivity (FC) in 34 users and 19 non-users, employing covariates. Ketamine users were categorized as adolescent-onset and adult-onset based on when they were first exposed to ketamine. Imaging data were processed by published routines in SPM and AFNI. The results revealed lower GMV in the left precuneus in ketamine users, with a larger decrease in the adolescent-onset group. The results from a seed-based correlation analysis show that both ketamine groups had higher functional connectivity between left precuneus (seed) and right precuneus than the control group. Compared to controls, ketamine users showed decreased GMV in the right insula, left inferior parietal lobule, left dorsolateral prefrontal cortex/superior frontal gyrus, and left medial orbitofrontal cortex. These preliminary results characterize the effects of ketamine misuse on brain structure and function and highlight the influence of earlier exposure to ketamine on the development of the brain. The precuneus, a structure of central importance to cerebral functional organization, may be particularly vulnerable to the influences of early ketamine exposure. How these structural and functional brain changes may relate to the cognitive and affective deficits remains to be determined with a large cohort of participants.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32968108      PMCID: PMC7512006          DOI: 10.1038/s41598-020-72320-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  88 in total

1.  Early-onset cannabis use and cognitive deficits: what is the nature of the association?

Authors:  Harrison G Pope; Amanda J Gruber; James I Hudson; Geoffrey Cohane; Marilyn A Huestis; Deborah Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492

2.  The impact of early-onset cannabis use on functional brain correlates of working memory.

Authors:  Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Jörg Daumann
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-04-02       Impact factor: 5.067

Review 3.  The role of setting for ketamine abuse: clinical and preclinical evidence.

Authors:  Maria Teresa De Luca; Maria Meringolo; Primavera Alessandra Spagnolo; Aldo Badiani
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

4.  Dysfunctional default mode network and executive control network in people with Internet gaming disorder: Independent component analysis under a probability discounting task.

Authors:  L Wang; L Wu; X Lin; Y Zhang; H Zhou; X Du; G Dong
Journal:  Eur Psychiatry       Date:  2016-02-27       Impact factor: 5.361

Review 5.  Cannabis cue-elicited craving and the reward neurocircuitry.

Authors:  Francesca M Filbey; Samuel J DeWitt
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-11-09       Impact factor: 5.067

6.  Altered prefrontal dopaminergic function in chronic recreational ketamine users.

Authors:  Rajesh Narendran; W Gordon Frankle; Richard Keefe; Roberto Gil; Diana Martinez; Mark Slifstein; Lawrence S Kegeles; Peter S Talbot; Yiyun Huang; Dah-Ren Hwang; Leyla Khenissi; Thomas B Cooper; Marc Laruelle; Anissa Abi-Dargham
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

7.  Emergence of GABAergic-dependent regulation of input-specific plasticity in the adult rat prefrontal cortex during adolescence.

Authors:  Adriana Caballero; Daniel R Thomases; Eden Flores-Barrera; Daryn K Cass; Kuei Y Tseng
Journal:  Psychopharmacology (Berl)       Date:  2013-08-02       Impact factor: 4.530

8.  Altered white matter integrity in adolescent binge drinkers.

Authors:  Tim McQueeny; Brian C Schweinsburg; Alecia D Schweinsburg; Joanna Jacobus; Sunita Bava; Lawrence R Frank; Susan F Tapert
Journal:  Alcohol Clin Exp Res       Date:  2009-04-21       Impact factor: 3.455

9.  Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users.

Authors:  Claudia B Padula; Alecia D Schweinsburg; Susan F Tapert
Journal:  Psychol Addict Behav       Date:  2007-12

10.  Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.

Authors:  J F William Deakin; Jane Lees; Shane McKie; Jaime E C Hallak; Steve R Williams; Serdar M Dursun
Journal:  Arch Gen Psychiatry       Date:  2008-02
View more
  4 in total

1.  Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

Authors:  Leah Vines; Diana Sotelo; Allison Johnson; Evan Dennis; Peter Manza; Nora D Volkow; Gene-Jack Wang
Journal:  Intell Med       Date:  2022-03-07

2.  Clinical and behavior characteristics of individuals who used ketamine.

Authors:  Tony Szu-Hsien Lee; Yi-Hsuan Liu; Yun-Ju Huang; Wai-Kwong Tang; Yifan Wang; Sien Hu; Ching-Po Lin; Chiang-Shan Ray Li; Chia-Chun Hung
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

3.  Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review.

Authors:  Jurriaan F M Strous; Cees J Weeland; Femke A van der Draai; Joost G Daams; Damiaan Denys; Anja Lok; Robert A Schoevers; Martijn Figee
Journal:  Front Neuroanat       Date:  2022-03-18       Impact factor: 3.856

4.  Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophrenia.

Authors:  Robert A Chesters; Fiona Pepper; Celia Morgan; Jonathan D Cooper; Oliver D Howes; Anthony C Vernon; James M Stone
Journal:  Psychopharmacology (Berl)       Date:  2021-07-06       Impact factor: 4.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.